Joseph Plante serves as Executive at THERAGENICS CORP, where they oversee executive responsibilities. Since joining the company, Joseph Plante has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 29, 2013 involved selling 219,175 shares valued at $482.2K.
Joseph Plante currently holds 219,175 shares of THERAGENICS CORP (TGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Plante has been a net neutral trader of TGX stock. They have purchased $0 and sold $0 worth of shares.
Joseph Plante's most recent insider trade was on Oct 29, 2013, when they sold 219,175 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted
| 54,308 |
| $2.20 |
| Discretionary |
| Feb 21, 2013 | TGX | $0 | Award | 128,000 | $N/A | Discretionary |
| Feb 24, 2012 | TGX | $0 | Award | 87,250 | $N/A | Discretionary |
| Mar 2, 2011 | TGX | $3.9K | Payment | 2,305 | $1.71 | Discretionary |
| Feb 25, 2011 | TGX | $0 | Award | 30,600 | $N/A | Discretionary |
| Mar 25, 2010 | TGX | $0 | Award | 26,000 | $N/A | Discretionary |